Practice Areas
|
Health Care Solutions
Lehman, Lee & Xu is one of the most well-respected and prominent consultants to the food and drug industry in China.
The Firm is legal counsel to the China Foreign Research-based Pharmaceutical Industry Association (FRPIA), an organization comprised of 38 of the foreign research-based pharmaceutical companies in China. The FRPIA was established to help shape the laws, regulations, standards, ethics, policies, and practices of the foreign pharmaceutical companies in China.
Providing an extensive range of services to our clients, we have worked with many large multinationals who have become prominent participants in the China market, including Aventis, Bristol Myers Squibb, Nycomed, Schering AG, Roche, GlaxoSmithKline and Novartis.
Our food and drug clients often seek consultation regarding new product approval, government regulations, advertising campaigns and the formation of new ventures within the pharmaceuticals and food industry. Our many years of experience working with the State Food and Drug Administration (SFDA) has proven to be indispensable in this industry.
The expertise of Lehman, Lee & Xu is not limited to pharmaceuticals and food, but also includes the emerging area of biotechnology. We have represented and counseled clients in such fields of research as molecular and cellular biology, DNA technology, immunology, transgenics and genomics. Our in-house patent agency and relationship with the State Intellectual Property Office (SIPO), which is responsible for the registration and administration of patents in China, has proven invaluable when preparing patent applications and litigating in the above-mentioned areas. We are also among the foremost experts on the licensing of foreign intellectual property rights in the biotechnology industry to local enterprises.
Our Food & Drug practice group is experienced in providing service in the following areas: - Due diligence with regards to joint venture partners, foreign trading company partners, and distributors in the food and drug industry;
- Every aspect of foreign invested pharmaceutical enterprise negotiation and documentation;
- Advice on the legal development of promotional/marketing strategies and implementation;
- Corporate setups for foreign invested pharmaceutical enterprises;
- Mergers and acquisitions of Chinese pharmaceutical companies;
- Establishment of foreign invested pharmaceutical enterprise; branches/representative offices across China;
- Non competition agreements and enforcement with regards to key pharmaceutical employees, such as national sales managers;
- Drafting and gathering documentation for filing administrative protection applications;
- Administrative or judicial enforcement of pharmaceutical patent and trademark rights;
- Negotiating and drafting pharmaceutical distribution agreements;
- Assistance in product registration issues;
- Drafting technology import contracts; and
- Debt management and collection with respect to Chinese distributors.
Click here for Health Care FAQs
|
